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Abstract
Objectives: To evaluate the state of chloroquine resistant malaria in the South West Province of Cameroon. 
To estimate the prevalence of different species of Plasmodium in the area.
Design: A cross' sectional study.
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A
Setting: South West Province of Cameroon. - 
Subjects: 326 febrile patients.
Main Outcome Measures: Chloroquine resistance studies using the WHO seven-day standard in vivo test. 
Speciation of malaria by polymerase chain reaction. Prevalence of falciparum malaria by light microscopy 
of thick blood smears.
Results: Prevalence of chloroquine resistance ranged from 4.3 to 13.2%. A total of six cases showed RIII 
resistance, and three cases showed RII resistance.
Plasmodium falciparum was the predominant species, 96.8% of those testing positive for P. falciparum, 6.3% 
of cases showed mixed infections of P. falciparum and P. malariae. P. ovale accounted for 3% of cases. 
Conclusion: P. falciparum resistance to chloroquine may not be on the increase compared to earlier reports 
from the South West Province. The results have important implications in treatment of malaria in view of the 
low cost of chloroquine.
Introduction
The control of malaria relies mainly on chemotherapy, 
chemoprophylaxis and the use of mosquito bed nets. The 
emergence and rapid spread of resistance of parasites and 
vectors to antimalarials and insecticides respectively has 
exacerbated the problem of control. Chloroquine is the 
most common and cheapest antimalarial drug available. 
Unfortunately, resistance to this drughas reached alarming 
proportions in most countries affected by Plasmodium 
falciparum malaria.
Drug resistance was first reported in the 1950s in South 
East Asia and South America.1 The first case of P. 
falciparum  chloroquine resistance in Cameroon was 
reported in Limbe, Fako Division.2 Subsequent studies 
confirmed that resistance had spread to different parts of 
the country.3'4 From 1989 to 1991 several in vivo studies 
were carried out in different bio-climatic areas in Cameroon. 
The results showed that the rate of chloroquine resistance 
varied from 6% in the Northern Savannah region to 42% in 
industrial zones like Edea where drug pressure was 
particularly high.5 Studies have shown that drug pressure 
facilitates the development of cross-resistance to 
antimalarial drugs.6
Although conventional microscopy has been the major 
method of identification of malaria parasites, proper reading 
and interpretation of results requires experience and 
expertise. The difficulty, which many laboratory technicians 
encounter in reading thick smears and interpreting the 
results correctly has resulted in the common practice by 
medical personnel of treating all febrile cases with 
antimalarials even when laboratory tests are reported 
negative. Correct identification of the various'plasmodial 
species using stained smears also demands expertise and 
for these reasons mixed infections and single infections 
due to species other than P. falciparum are often missed. 
The superiority of the polymerase chain reaction 
amplification technique over microscopy was clearly 
demonstrated in a field study in Thailand where 16% of 
infected samples were missed, 3% misdiagnosed and 13% 
mixed infections missed.7 PCR amplification is sensitive 
and accurate enough to detect as low as four parasites per 
microlitre by gel electrophoresis.
The objectives of this study were firstly to evaluate the 
state of chloroquine resistant malaria in the South West 
Province 13 years after it was first reported and secondly, 
to obtain accurate information on the prevalence of the 
different species of Plasmodium in the area using the more 
sensitive PCR amplification technique.
Materials and Methods
Study Design and Sampling.
A random cluster sampling was used to evaluate 
chloroquine resistance in the study populations. All malaria 
patients recruited into the study had to have been bom in 
the study area (in the case of children less than two years 
old) or must have lived in the study area for at least two 
years. For inclusion into the study, the patient was not to 
have received any form of malaria treatment within the 
previous 14 days as confirmed with the Saker-Solomons 
urine test.8 In addition the patient was required to have a 
parasite count of at least 1 000 per ml of blood. After the 
first day (DO) of sampling, each patient returned for 
further sampling and follow up on the second day (Dl), the 
third day (D2) and the eighth day (D7).
Study Areas.
All three areas from which patients were recruited are 
located in the South West Province of Cameroon. These 
areas are mesoendemic for malaria in the dry season and 
hyperendemic in the rainy season. The semi-urban town of 
Tiko has a population of 14 000 inhabitants. The area is 
almost entirely at sea level, with a small region that is 20 
to 40 metres above sea level. The majority of inhabitants 
are plantation workers of the Cameroon Development 
Corporation (CDC). Limbe is a larger town with a 
population of 200 000 engaged in varied professions. 
Many parts of Limbe are at sea level with a few being 30 
to 80 metres above sea level. Molyko is a village in the 
South West provincial capital of Buea and has a population 
of approximately 10 000 inhabitants of which 75% are 
students. The village is situated 580 to 630 metres above 
sea level at the foot of Mount Cameroon. All three areas 
have a rainy season (March to October) and a dry season 
(November to February).
Cent AfrJ Med 2001;47(6) 146
Study Population.
A total of 326 febrile participants between the ages of 
one to 51 years and of both sexes were recruited into the 
study after individual or parental consent. Of these 113 
(one to 41 years old) were recruited at the CDC Central 
Clinic in Tiko; 150 (one to 51 years old) from the Provincial 
Hospital in Limbe and 63 (one to 40 years old) from the 
University of Buea Health Unit and private clinics in 
Molyko. The study period between January and April 1998 
coincided with the dry and rainy seasons. Ethical clearance 
was obtained-from Ethical Review Board m f fEe South 
West Province. ' '
The Simplified WHO Seven Day Test to Detect 
Chloroquine Resistance.
The procedure used was as outlined by WHO (1973) and 
similar to the in vivo seven day assay used in 1987 to 
evaluate chloroquine resistance in Cameroon.3 Baseline 
data using 14 days follow up showed a similar trend as 
obtained using the seven day test. However, a disadvantage 
was the high rate of withdrawal of patients from the study 
during 14 days of observation. Essentially, on DO, D2 and 
D7, thick smears were done on each subject. On DO, D1 
and D2 each individual received orally chloroquine tablets 
containing lOOmg chloroquine base (Cinpharm, Cameroon) 
at doses of lOmg/Kg on DO and DI and 5 mg/kg on D2. The 
drug was administered each day as a single dose with water 
and the patient was observed for 15 minutes after intake. 
When necessary, the patients were visited at home to 
complete treatment. Patients in whom parasites were still 
detected on D7 were referred to the doctor for further 
treatment with alternative drugs. Parasite densities were 
determined by microscopy after staining thick smears with 
fields’s stain. Parasites were enumerated following the 
procedure outlined by Earle and Perez.9 At least 100 
microscopic fields were scanned prior to reporting any 
result as negative.
Parasite DNA Extraction.
About 2 ml of blood samples were each collected into 
tubes containing sodium citrate. The blood samples were 
stored at -20°C at the University of Buea research laboratory 
and later transported on ice to the Biotechnology Centre at 
the University of Yaounde. At the Centre the blood samples 
were dispensed^into I.5ml eppendorf tubes, centrifuged at 
1 000 x g for five minutes and the supernatant discarded.' 
Each volume was made up to 500 ml with Tris Sodium 
Chlorid EDTA buffer. The samples were stored at -20°C 
overnight. Parasite DNA was extracted using phenol. The 
extracted DNA was precipitated by addition of ethanol 
followed by centrifugation. The pellets were washed, dried 
and dissolved in Tris-EDTA buffer and stored at -20°C 
until PCR amplification.
PCR Amplification.
All PCR reactions were carried out in a total volume of 
20 ml containing 2mM MgCL2,50mM KCL, lOmM Tris- 
HCL(PH 8.3), 0.1 mg/ml gelatin, 125 micromolar of each 
of the deoxyriboncleotide triphosphates (dNTp) and 0.4 
units of amplitag polymerase. One microlitre of the purified
template DNA extracted from the blood was used for the 
SPE-Nest I (SNI) reaction in which the fragment spanned 
by the primers rPLU5(CCTGTTGTTGCCTTAAACTTC) 
and rPLU(TTAAAATTGTTGTTGCAGTTAAAAGC) 
was amplified (these primers were validated by Snounou 
et al? and are highly sensitive). This was to detect the 
presence of the genus Plasmodium. One microlitre of the 
product of SNI reaction was employed as DNA template in 
the SPE_-Nest 2(SN2) reaction in which the species-specific 
.oligonucleotide primer pairs were used.7 The negative 
controls were FMO (F = P. falciparum; M = P. malariae; 
0=P.  ovale) both obtained from Georgetown University, 
Maryland, USA (Courtesy of Dr Diane Taylor) and the 
Biotechnology Centre, Yaounde. The amplification assays 
were performed in a DNA thermal cycler at the 
biotechnology Centre. The amplified products were run on 
agarose gels, visualized under a UV transilluminator and 
photographed.
Statistical Analysis.
The Chi square test with p<0.05 was used to determine 
the level of significance.
Results
Prevalence of Malaria.
Of the 326 individuals recruited into the study 247 
(75.8%) were positive. The prevalence of malaria as- 
determined by micoscopy was 82.3% and 69.8% for Tiko, 
Limbe and Buea respectively (Table I). Parasite counts 
ranged froml 040 to 120 000 parasites per pi of blood.
Table I: The prevalance of malaria per locality.
Locality
N o. ot
positive
patien ts
N o. of
negative
patien ts T o ta l P reva lan ce
Tiko 93 20 113 82 .3%
Limbe 110 40 150 73.3%
Buea 44 19 63 69.8%
WHO in vivo Seven Day Test.
Of the 247 patients with a positive diagnosis, only 122 
agreed to be treated with chloroquine and followed up 
thereafter for detection of chloroquine resistance. Resistant 
parasite strains were detected in 10 patients of whom two, 
seven and one were from Tiko, Limbe and Buea 
respectively. There were a total of 4 R l l  and 6.RIII type 
resistance detected (Table II). No statistically significant 
difference (p>0.05) was observed in the pattern of sensitivity 
and resistance between the three areas.
Parasite Counts at the Various Levpls of Resistance.
Classification into the different levels of resistant types 
was based on parasite counts on DO, D2 and D7. The mean 
parasite count in cases of R l l  type resistance dropped 
appreciably from DO to D2 but by D7, a fourfold increase 
was recorded (Table III). In cases with RIII type resistant 
parasite strains, parasite counts continued to increase 
steadily from DO to D7.
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Table II: Prevalence of chloroquine sensitivity in the three 
areas studied.
Loca lity
S en s itive  to  
ch lo ro q u in e
C h lo roqu ine  
res is tance  
R11 R111
No.
tes ted
P reva lence  of 
res is tance  (% ) 
^C o n fid e n c e *  
In te rval*
Tiko 45 1 1 47 4 .3±  5 .79
Lim be 46 2 5 53 , 13.2 ± 9 .11
B u ea 21 1 0 22 . •4.5 ± 8 .6 6
Tota l 112 4 6 112 8 1 2 + 4 .8 6
Chi-square=3,131. *5% signficant. 
Degrees of freedom=2. p>0.05.
Table III: Evolution o f parasitaemia in patients with 
resistant P,falciparum.
R esistance
level
N o. o f 
cases DO D 2 . D7 .
Rll 4 21 400 26 530 26 500
(± 10 374 .97 ) (± 14 233.52) (±12 257.65)
R ill 6 18 4 0 3 .33  ■ 23 8 2 6 .67 25 .333 .33
(± 1 0  770 .33 ) (± 1  136.51) (± 1 0 .9 82 .2 1 )
Plasmodium Species Detected by PCR.
A total of 96 positive blood samples as detected using 
microscopy were analysed for speciation by PCR. An 
equal number of 32 samples each were randomly selected 
from samples collected in the three study areas. The genus 
specific primers strongly hybridized with RNA from blood 
with all four species of malaria parasites. No significant 
signals were detected with human DNA or in the absence 
of DNA isolates (negative controls). Visible bands were 
detected on all four positive controls (FMO was used as 
positive control' for P. falciparum, P. malariae and P. 
ovale respectively while a separate control was used forP. 
vivax). Of the 96 samples analysed by PCR, 93 (96.8%) 
were positive forP. falciparum and three forP. ovale (3%). 
Of those positive forP. falciparum six (6.3%) had a mixed 
infection with P. malariae(Tab\&YV).'HoP. vivax infection 
was detected.
Table IV: Prevalence of the different Plasmodium species 
in the study areas.
S pecies T iko  n *=32 L im b e  n=32 B uea n=32 Tota l n=126
P : fa lc iparum 29 (90.6% ) 28 (87.5% ) 30 (93.8% ) 87 (90.6% )
P. ova le 1 (3.1% ) 2 (6 .3% ) 0 3 (3.1% )
P. fa lc ipa rum  &  
P. m a la riae 2 (6 .3 % ) 2 (6.3% ) 2 (6.3% ) „ 6 (6.3% )
* n= number of samples.
Discussion
The results from this study indicated that resistance to 
chloroquine in the South West of Cameroon has dropped 
since it was first reported. The status of drug resistant P. 
falciparum in the Southern part of Cameroon as determined 
from 1987 to 1988 clearly showed R lland R i l l  levels of
resistance in 18 and 62% respectively of the 389 cases 
studied.10 The overall prevalence for resistance was 85.08% 
(Cl = 1.96). While there are no previous figures on the level 
of chloroquine resistance in Buea, the prevalence of 
resistance from our study was 4.3%, 13.2% and 4.5% for 
Tiko, Limbe and Molyko (Buea) respectively with an 
overall prevalence of 8.2% (Cl = 4.86); An earlier study 
had reported a resistance level of 20.6% in Tiko and 55% 
in Limbe.11
Since the first reports of chloroquine drug resistance in 
the mid 1980’s the use of this drug as the first line drug for 
treatment of uncomplicated P. falciparum malaria in the 
study areas was discouraged. As a result, many physicians 
stopped the use of chloroquine as the first line drug. 
Results of a questionnaire that was administered in the 
study areas on the types of antimalarial used in self- 
medication showed a frequency rate of 45.5%, 35.9% and 
16.3% for sulfadoxine pyrimethamine, quinine sulfate and 
chloroquine respectively (unpublished data). This further 
. indicated that chloroquine was no longer used frequently. 
The itching effect of chloroquine which makes it 
unattractive to many patients has also contributed to the 
infrequent use of this drug. It was noticed from the present 
study, however, that of 13 individuals with malaria who 
claimed to be allergic to chloroquine, only one of these 
experienced pruritis following oral chloroquine intake. 
The others were able to complete the dose for treatment 
without further complains. Furthermore none of the patients 
vomited during the course of the study. All of the above 
factors seem to have contributed to a significant reduction 
in chloroquine drug pressure.
The standard seven day test was used in this study 
because it is appropriate in detecting R l l  and R i l l  type 
resistance12 which had previously been reported to be the 
common types in the study areas. The parasitaemia reported 
in the study ranged from 1 040 to 120 000 parasites/ml of 
blood. Although parasitaemia was generally not high 
because of the period of study, a relatively true prevalence 
of resistance was obtained. Although the primers used in 
our study have been validated elsewhere, this is the first 
study in South West Cameroon in which parasite speciation 
has been done using such, a sensitive technique. The 
findings are therefore significant. P. falciparum was found 
to be the predominant species in all three areas accounting 
for 96.8% of all positive cases. This study has provided 
additional information with the finding that P. malariae 
occurred in 6.3% of positive cases as mixed infections with 
P.falciparumwYiWeP. ovale accounted for single infections 
in 3% of positive cases. The superiority of the PCR 
technique over slide microscopy is evident from the fact 
that two of the three cases of P. ovale infections and four 
mixed infections were missed by microscopy. Information 
on proper speciation of’ parasites is essential for the 
institution of effective treatment of malaria.
Our results indicated that there was no significant 
influence of altitude on the prevalence of malaria in the
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three areas studied (p>0.05). It is expected that with 
Molyko situated at a higher altitude than Tiko and Limbe 
a significant difference in prevalence would have been 
observed. It is worth mentioning that between 1993 when 
the University of Buea was opened and the present date, the 
population of Molyko has just about doubled and this 
could have brought about a significant change in the 
epidemiology of malaria in this area. Unfortunately there 
are no previous data on prevalence studies in Molyko for 
comparison. Further investigations at much higher altitudes 
in Buea are necessary to be more conclusive.
In conclusion, the data from our study showed that P. 
falciparum resistance to chloroquine may no longer be 
such an alarming problem as reported earlier in some areas 
of the South West Province. The results presented here 
have important implications in the treatment of malaria 
considering that chloroquine remains the cheapest 
antimalarial in Cameroon. The drug is generally well 
tolerated. We suspect that the decline in chloroquine 
resistance may well reflect a decrease in drug pressure over 
the years. The superiority of the PCR technique with 
reference to slide microscopy was also evident.
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